Avent (etanercept biosimilar) / Avesthagen - LARVOL DELTA

The Accuracy of a SmartBottle Device for Objective Assessment of Changes in Bottle Weight During Infant Feeding. (PubMed, J Acad Nutr Diet) - "SmartBottle-derived test weights were equivalent to scale-derived criterion weights within ±5% equivalence bounds with no evidence of bias. Further testing within real-world infant feeding contexts is warranted."

Journal

Biosimilars Match Biologic Originators in Rheumatoid Arthritis (RheumNow) - "A systematic review and meta-analysis in JAMA Network Open has shown that biosimilars of adalimumab, infliximab, and etanercept were associated with clinically equivalent treatment effects compared with their reference biologics for the treatment of rheumatoid arthritis (RA)....This review finds that biosimilars may yield therapeutically equivalent outcomes compared with reference biologic drugs for the management of rheumatoid arthritis."

Online posting

"$PHG Parent's Path Art Collection by Philips Avent Showcases the Uniqueness of Each Parenting Journey https://t.co/4nmaskUm2P #stocks" (@stock_titan)

""Les morts sont pati" Oui mon ami. Faudrait pas oublier de prendre votre sirop avent de dormir." (@MarcAntoineSai5)

"@23andMe Hi, My Birthday is January 6, 2023. Do you have daily, avent company birthday giveaway/assistance gifts to share leading up and also now?" (@DwayneTriplett1)

"Pouvez vous me parler des gens crado qui se l'avent pas les mains et choppes des infections ?" (@Dr_kodi_)

Infectious Disease

"Le calendrier de l'Avent des publications des membres du GAVO2. J-18. @DrGonzalezJesus et ses collègues montrent que les impressions 3D comme pièce de VNI c'est bof.. https://t.co/HAbZh8UD58" (@GAVSPLF)

"@AstraZenecaFR et @Pfizer_France ont sorti un calendrier de l'avent..." (@Excocet71)

Interleukin Inhibitors for Moderate to Severe Psoriasis (HMP Global) - "Dr Armstrong moved on to a discussion of the biologics available to treat plaque psoriasis. The first class is anti-TNα therapies, which 'can work 'upstream' as well as 'downstream.' The FDA-approved TNF inhibitors are etanercept, adalimumab, infliximab, and certolizumab. Next are the FDA approved IL-17 inhibitors: secukinumab, ixekizumab, brodalumab. Secukinumab and ixekizumab have 'identical mechanism of action, binding to IL-17A, and they treat both psoriasis as well as psoriatic arthritis,' stated Dr Armstrong.'"

Media quote

"$PHG Philips Avent Evolves Portfolio with Suite of Product Innovations and Enhancements https://t.co/8t6laUdnPo" (@stock_titan)

"$PHG Philips Avent Launches New Electric Breast Pump Inspired by Baby's Natural Feeding Motion https://t.co/QO1G4V8469" (@stock_titan)

Inflammatory Conditions Help Drive Another Strong Year for Specialty - "Aimee Tharaldson, PharmD...predicted that once all of the numbers are in, specialty drugs will have outpaced traditional medications in 2020 and that trend would continue this year. Inflammatory conditions stood out in the Express Scripts report...Tharaldson noted during the AMCP Nexus 2020 virtual meeting. 'This was by far the No. 1 therapy class based on per member per year [PMPY] spending,' she said, citing two dominant contributors: adalimumab (Humira, AbbVie) and etanercept (Enbrel, Amgen)."

Media quote

Adaptive capacity of 2- to 5-month-old infants to the flow, shape, and flexibility of different teats during bottle feeding: a cross-sectional study. (PubMed, BMC Pediatr) - "Healthy infants aged 2-5 months can adapt to the flow, shape, and flexibility of different teats, showing a wide range of biomechanical and motor adaptations."

Journal • Observational data

"Bibou is closed, and Pierre and Charlotte Calmels plan to reopen it as a French grocery -- Moi, je suis un peu desole mais aussi cette nouvelle est excite. En avent! https://t.co/oIQjgygeUy via @phillyinquirer" (@jasonkarlawish)

Tracker-Based Personal Advice to Support the Baby's Healthy Development in a Novel Parenting App: Data-Driven Innovation. (PubMed, JMIR Mhealth Uhealth) - "Parents experienced the insights in the uGrow app as useful and reassuring and as adding enjoyment to their use of the uGrow app and tracking their baby's development. The insights development process we followed showed how the quality of insights can be guaranteed by ensuring that insights are relevant, appropriate, and evidence based. In this way, insights are an example of meaningful DDI."

Clinical • Journal